These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 769959)

  • 21. A comparative clinical trial of adriamycin and 5-fluorouracil in advanced prostatic cancer: prognostic factors and response.
    DeWys WD; Begg CB; Brodovsky H; Creech R; Khandekar J
    Prostate; 1983; 4(1):1-11. PubMed ID: 6340081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adriamycin (NSC-123127) therapy for advanced gastrointestinal cancer.
    Frytak S; Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
    Cancer Chemother Rep; 1975; 59(2 Pt 1):405-9. PubMed ID: 1097099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of 5-fluorouracil and adriamycin in transitional cell carcinoma of the urinary tract.
    Martino S; Samal B; Al-Sarraf M
    Cancer Treat Rep; 1980 Jan; 64(1):161-3. PubMed ID: 7379051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. cis-Platinum combination chemotherapy of bladder cancer: an update.
    Williams SD; Einhorn LH; Donohue JP
    Cancer Clin Trials; 1979; 2(4):335-8. PubMed ID: 394869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinoma.
    De Palo GM; De Lena M; Bonadonna G
    Cancer Treat Rep; 1977; 61(3):355-7. PubMed ID: 326402
    [No Abstract]   [Full Text] [Related]  

  • 26. Muehrcke's lines on nails after cyclophosphamide/adriamycin/fluorouracil.
    Gül U; Kiliç A
    Ann Pharmacother; 2004 Jun; 38(6):1089-90. PubMed ID: 15122002
    [No Abstract]   [Full Text] [Related]  

  • 27. [Efficacy of doxorubicin (adriamycin) in disseminated forms of breast cancer].
    Trofimova NB; Gorbunova VA
    Antibiotiki; 1983 Aug; 28(8):625-8. PubMed ID: 6638976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report.
    Bruckner HW; Pagano M; Falkson G; Creech R; Arseneau JC; Horton J; Brodovsky H; Davis TE; Slayton RW; Greenspan E
    Cancer Treat Rep; 1979 Feb; 63(2):297-9. PubMed ID: 376136
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase II study of adriamycin, 5-fluorouracil, levamisole, and irradiation in carcinoma of the bladder.
    Lundbeck F; Christophersen IS
    Cancer Treat Rep; 1979 Feb; 63(2):183-8. PubMed ID: 445495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.
    Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D
    N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer.
    Higby DJ; Wilbur D; Wallace HJ; Henderson ES; Weiss R
    Cancer Treat Rep; 1977 Aug; 61(5):869-73. PubMed ID: 329980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I study of a combination of azotomycin (NSC-56654) and 5-fluorouracil (NSC-19893) in malignant disease.
    Weiss AJ; Mastrangelo MJ
    Cancer Chemother Rep; 1970 Apr; 54(2):109-11. PubMed ID: 4946000
    [No Abstract]   [Full Text] [Related]  

  • 33. [Continuous venous infusion in cancer chemotherapy].
    Ota K
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):798-805. PubMed ID: 2580486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary report on the use of CCNU (NSC-79037), adriamycin (NSC-123127), and hexamethylmelamine (NSC-13875) in carcinoma of the lung.
    Wilson WL; Andrews NC; Frelick RW; Nealon TF; Bick RL; Adams T
    Cancer Treat Rep; 1976 Mar; 60(3):269-71. PubMed ID: 816467
    [No Abstract]   [Full Text] [Related]  

  • 35. 5-Fluorouracil (NSC-19893) therapy for pancreatic carcinoma: comparison of oral and intravenous routes.
    Stolinsky DC; Pugh RP; Bateman JR
    Cancer Chemother Rep; 1975; 59(5):1031-3. PubMed ID: 1106846
    [No Abstract]   [Full Text] [Related]  

  • 36. Adriamycin in the treatment of cancer.
    van Dyk JJ; van der Merwe AM; Falkson HC; Falkson G
    S Afr Med J; 1976 Jan; 50(3):61-6. PubMed ID: 1251278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin in the treatment of advanced breast cancer; comparative studies of three combination chemotherapy regimes.
    Brown I; Ward HW
    Clin Oncol; 1976 Jun; 2(2):105-11. PubMed ID: 954258
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of combination adriamycin (NSC-123127) and DTIC (NSC-45388) in children with advanced stage IV neuroblastoma.
    Leikin S; Bernstein I; Evans A; Finklestein J; Hittle R; Klemperer M
    Cancer Chemother Rep; 1975; 59(5):1015-8. PubMed ID: 1106842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil.
    Kessinger MA; Foley JF; Lemon HM
    Cancer Clin Trials; 1979; 2(4):317-9. PubMed ID: 394867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative trial of adriamycin and 5-fluorouracil in advanced prostatic cancer--progress report.
    DeWys WD; Bauer M; Colsky J; Cooper RA; Creech R; Carbone PP
    Cancer Treat Rep; 1977; 61(2):325-8. PubMed ID: 326401
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.